• Latest Posts

Minoryx can start phase 3 trial for cerebral adrenoleukodystrophy patients

Minoryx Therapeutics announces X-linked adrenoleukodystrophy data

More News! 14 Nov 2022

Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease

Minoryx and Neuraxpharm announce license agreement to further X-ALD treatment

In Depth 8 Oct 2018

Behind the Scenes of the Spanish Biotech Industry’s Boom

Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline


A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

And We’re Off! First Patient Dosed in this Spanish Biotech’s Rare Disease Trial

Interview 10 Jul 2017

Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease

A Potential First Treatment for a Rare Genetic Disease clears Phase I

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017